From interleukin-23 to T-helper 17 cells: human T-helper cell differentiation revisited

Katia Boniface, Bianca Blom, Yong-Jun Liu, René de Waal Malefyt

Research output: Contribution to journalReview articleAcademicpeer-review

191 Citations (Scopus)

Abstract

Protracted inflammation leading to dysregulation of effector T-cell responses represents a common feature of a wide range of autoimmune diseases. The interleukin-12 (IL-12)/T-helper 1 (Th1) pathway was thought to be responsible for the pathogenesis of multiple chronic inflammatory diseases, including psoriasis, inflammatory bowel disease, arthritis, or multiple sclerosis, mainly through their production of interferon-gamma and its effects on macrophage activation and chemokine production. However, this initial concept of T-cell-mediated chronic inflammation required an adjustment with the discovery of an IL-12-related cytokine, designated IL-23. IL-23 was rapidly recognized for its involvement in the establishment of chronic inflammation and in the development of a Th cell subset producing IL-17, designated Th17, which is distinct from the previously reported Th1 and Th2 populations. This review aims to describe the characterization of IL-23 and its receptor, its biological activities, as well as its involvement in the development of human Th17 cells and autoimmunity
Original languageEnglish
Pages (from-to)132-146
JournalImmunological reviews
Volume226
Issue number1
DOIs
Publication statusPublished - 2008

Cite this